Fate Therapeutics Inc (FATE)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$1.29
Buy
$1.32
$0.07 (+5.65%)
Prices updated at 03 May 2025, 00:36 EDT
| Prices minimum 15 mins delay
Prices in USD
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
Key dates
| Forecast date | |
|---|---|
| Annual report | Mar 2026 |
| Final results | Mar 2026 |
| Half yearly results | Aug 2025 |
| Annual general meeting | Jun 2025 |
| Previous date | |
|---|---|
| Annual report | Mar 2025 |
| Final results | Mar 2025 |
| Half yearly results | Aug 2024 |
| Annual general meeting | Jun 2024 |
Company reports
31 Dec 2023
Annual Report 30 Sep 2023
Quarterly Report 